173 related articles for article (PubMed ID: 22348277)
1. A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint.
Zigler CM; Belin TR
Biometrics; 2012 Sep; 68(3):922-32. PubMed ID: 22348277
[TBL] [Abstract][Full Text] [Related]
2. Evaluating candidate principal surrogate endpoints.
Gilbert PB; Hudgens MG
Biometrics; 2008 Dec; 64(4):1146-54. PubMed ID: 18363776
[TBL] [Abstract][Full Text] [Related]
3. Design and estimation for evaluating principal surrogate markers in vaccine trials.
Huang Y; Gilbert PB; Wolfson J
Biometrics; 2013 Jun; 69(2):301-9. PubMed ID: 23409839
[TBL] [Abstract][Full Text] [Related]
4. Solutions for surrogacy validation with longitudinal outcomes for a gene therapy.
Roberts EK; Elliott MR; Taylor JMG
Biometrics; 2023 Sep; 79(3):1840-1852. PubMed ID: 35833874
[TBL] [Abstract][Full Text] [Related]
5. Evaluating surrogate markers of clinical outcome when measured with error.
Dafni UG; Tsiatis AA
Biometrics; 1998 Dec; 54(4):1445-62. PubMed ID: 9883544
[TBL] [Abstract][Full Text] [Related]
6. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
Taylor JM; Conlon AS; Elliott MR
Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
[TBL] [Abstract][Full Text] [Related]
7. Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm.
Roberts EK; Elliott MR; Taylor JMG
Stat Med; 2021 Dec; 40(29):6605-6618. PubMed ID: 34528260
[TBL] [Abstract][Full Text] [Related]
8. Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.
Conlon AS; Taylor JM; Elliott MR
Biostatistics; 2014 Apr; 15(2):266-83. PubMed ID: 24285772
[TBL] [Abstract][Full Text] [Related]
9. Evaluating a surrogate endpoint at three levels, with application to vaccine development.
Gilbert PB; Qin L; Self SG
Stat Med; 2008 Oct; 27(23):4758-78. PubMed ID: 17979212
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.
Zhou J; Chu H; Hudgens MG; Halloran ME
Stat Med; 2016 Jan; 35(1):53-64. PubMed ID: 26194767
[TBL] [Abstract][Full Text] [Related]
11. Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials.
Collier W; Haaland B; Inker LA; Heerspink HJL; Greene T
BMC Med Res Methodol; 2024 Feb; 24(1):39. PubMed ID: 38365599
[TBL] [Abstract][Full Text] [Related]
12. Bayesian estimation of the proportion of treatment effect captured by a surrogate marker.
Cowles MK
Stat Med; 2002 Mar; 21(6):811-34. PubMed ID: 11870819
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis for the evaluation of potential surrogate markers.
Daniels MJ; Hughes MD
Stat Med; 1997 Sep; 16(17):1965-82. PubMed ID: 9304767
[TBL] [Abstract][Full Text] [Related]
14. Comparing biomarkers as trial level general surrogates.
Gabriel EE; Daniels MJ; Halloran ME
Biometrics; 2016 Dec; 72(4):1046-1054. PubMed ID: 27038302
[TBL] [Abstract][Full Text] [Related]
15. A semiparametric Bayesian approach to the random effects model.
Kleinman KP; Ibrahim JG
Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
[TBL] [Abstract][Full Text] [Related]
16. Accommodating missingness when assessing surrogacy via principal stratification.
Elliott MR; Li Y; Taylor JM
Clin Trials; 2013; 10(3):363-77. PubMed ID: 23553326
[TBL] [Abstract][Full Text] [Related]
17. A bayesian approach to surrogacy assessment using principal stratification in clinical trials.
Li Y; Taylor JM; Elliott MR
Biometrics; 2010 Jun; 66(2):523-31. PubMed ID: 19673864
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
Jiang Z; Song Y; Shou Q; Xia J; Wang W
Trials; 2014 Dec; 15():500. PubMed ID: 25528466
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.
Gilbert PB; Bosch RJ; Hudgens MG
Biometrics; 2003 Sep; 59(3):531-41. PubMed ID: 14601754
[TBL] [Abstract][Full Text] [Related]
20. Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.
Gilbert PB; Hudgens MG; Wolfson J
Int J Biostat; 2011; 7(1):Article 36. PubMed ID: 22049267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
